pegcantratinib   Click here for help

GtoPdb Ligand ID: 11609

Synonyms: CT-327 | CT327 | K-252a-PEG2K | Pegylated K-252 | SNA-120 | SNA120
Compound class: Synthetic organic
Comment: Pegcantratinib (CT-327/SNA-120) is a clinical stage agent that inhibits the intracellular kinase domain of tropomyosin-related receptor kinase A (TrkA; NTRK1). TrkA is the high affinity receptor for nerve growth factor (NGF), and is a key target in pruritus, within the NGF-TrkA-TRPV1 pathway. As a TrkA inhibitor pegcantratinib is being evaluated as a potential topical treatment for inflammatory skin conditions. Chemically it is a 2kDa PEG derivative of K-252a that was originally developed by Sienna Biopharmaceuticals. PEG conjugation facilitates the delivery of high levels of the active ingredient to skin cells, and avoids the systemic side effects associated with an orally delivered version of the drug.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 113.26
Molecular weight 580.2
XLogP 5.11
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COCCOCCN1C(=O)OC2(C1=O)CC1OC2(C)n2c3ccccc3c3c2c2n1c1ccccc1c2c1c3CNC1=O
Isomeric SMILES COCCOCCN1C(=O)OC2(C1=O)CC1OC2(C)n2c3ccccc3c3c2c2n1c1ccccc1c2c1c3CNC1=O
InChI InChI=1S/C32H28N4O7/c1-31-32(29(38)34(30(39)43-32)11-12-41-14-13-40-2)15-22(42-31)35-20-9-5-3-7-17(20)24-25-19(16-33-28(25)37)23-18-8-4-6-10-21(18)36(31)27(23)26(24)35/h3-10,22H,11-16H2,1-2H3,(H,33,37)
InChI Key MTDVEOMKVDOULD-UHFFFAOYSA-N

For advanced searching click here to open chemical structure editor

Similar Ligands Click here for help
K-252a
Click here for ligand page
Targets
Calmodulin-dependent kinase II; M1 receptor; large tumor suppressor kinase 1; neurotrophic receptor tyrosine kinase 1
KT 5720
Click here for ligand page
Targets
M1 receptor; M4 receptor
KT 5823
Click here for ligand page
Targets
M1 receptor; M2 receptor
staurosporine
Click here for ligand page
Targets
TRAF2 and NCK interacting kinase; calcium/calmodulin-dependent protein kinase II beta subunit; death associated protein kinase 1; large tumor suppressor kinase 1; large tumor suppressor kinase 2; mitogen-activated protein kinase kinase 4; mitogen-activated protein kinase kinase 6; p21 (RAC1) activated kinase 2; phosphorylase kinase catalytic subunit gamma 2; protein kinase C iota; protein kinase N1; protein kinase, cAMP-dependent, catalytic, beta subunit; serine/threonine kinase 3
lestaurtinib
Click here for ligand page
Targets
fms related receptor tyrosine kinase 3; large tumor suppressor kinase 1; large tumor suppressor kinase 2
midostaurin
Click here for ligand page
Targets
fms related receptor tyrosine kinase 3; large tumor suppressor kinase 1; large tumor suppressor kinase 2
7-hydroxystaurosporine
Click here for ligand page
Targets
3-phosphoinositide dependent protein kinase 1; LCK proto-oncogene, Src family tyrosine kinase; checkpoint kinase 1; checkpoint kinase 2; cyclin dependent kinase 1; glycogen synthase kinase 3 beta; microtubule affinity regulating kinase 1; mitogen-activated protein kinase 14; protein kinase A; protein kinase C alpha; protein kinase C beta; protein kinase C delta; protein kinase C epsilon; protein kinase C gamma
CEP-1347
Click here for ligand page
Targets
mitogen-activated protein kinase kinase kinase 10; mitogen-activated protein kinase kinase kinase 11; mitogen-activated protein kinase kinase kinase 12; mitogen-activated protein kinase kinase kinase 9
TTT-3002
Click here for ligand page
Targets
fms related receptor tyrosine kinase 3; leucine rich repeat kinase 2